Stanley Capital Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, Stanley Capital has acquired 3 companies.

Stanley Capital’s most common sectors for investment arelife science (67%) and software (34%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (34%) and divestiture (34%). In total, Stanley Capital has invested in 3 different countries. Its largest (disclosed) acquisition occurred in 2020 when it acquired Noden Pharma DAC for $53M.

In the last 3 years, Stanley Capital has exited 1 company. The Firm’s most common exit type is unknown (100%).

Join Mergr to view Stanley Capital’s full profile and discover more small private equity firm investors just like it.

M&A Summary

  • M&A Total Activity4
    • M&A Buy Activity3
    • M&A Sell Activity1
  • Total Sectors Invested 2
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 1

Stanley Capital

Stanley Capital Partners LLP

1 Old Queen St,
London, SW1H 9JA
United Kingdom
www.stanley-capital.com
info@stanley-capital.com

Stanley Capital is a private equity partnership that pursues healthcare and technology investments. The Firm targets businesses valued from $250 million to $2.5 billion with defensible business models and opportunities for growth. Stanley Capital was formed in 2019 and is headquartered in London.


Investment Criteria

Sectors of Interest: Healthcare Services, Information Technology, Life Science, Software

Target Transaction Types: Buyout (LBO, MBO, MBI), Divestiture

Geographic Preferences: United Kingdom

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value 250 2,500
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '18 '19 '20 '21 '22 '23 T
Buy (0.6/yr) # - - 1 - 2 - 3
vol $53M $53M
Sell (0.2/yr) # - - - - 1 - 1
  4

Most Recent M&A

Company Date Value Type
Noden Pharma DAC 2022-10-11 - Unknown
Dublin, Ireland · www.nodenpharma.com
Laboratoire X.O 2022-10-04 - Secondary Buyout
Saint-Cloud, France · www.laboratoirexo.fr
Qinecsa Solutions 2022-01-01 - Buyout (LBO, MBO, MBI)
London, United Kingdom · www.qinecsa.com
Noden Pharma DAC 2020-09-09 53M USD Divestiture
Dublin, Ireland · www.nodenpharma.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 1 (50%) - 2 (67%) 53M (100%)
Software 1 (50%) - 1 (33%) -
Total 2 - 3 $53M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United Kingdom 1 (50%) - 1 (33%) -
France 1 (50%) - 1 (33%) -
Ireland - - 1 (33%) 53M (100%)
Total 2 - 3 $53M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Divestiture - - 1 (33%) 53M (100%)
Buyout (LBO, MBO, MBI) 1 (50%) - 1 (33%) -
Secondary Buyout 1 (50%) - 1 (33%) -
Total 2 - 3 $53M

Exits by Deal Type

Type Total # Value
Unknown 1 (100%) -
Total 1 -

Deal Values

buy # Total
< $100M 1 $53M
TOTAL $53M
Largest Noden Pharma DAC
$53M (2020-09-09)

M&A Connections

Deals
Acquired from
Investor(s)
33%
1 (33%)
Strategic(s)
33%
1 (33%)

Investor Summary

Investor Type

Private Equity Firm

Size

Small

Established

2019

Specialist/Generalist

Specialist

Leadership

James Brooks

Founding Partner

Patrick Hargutt

Founding Partner

Simon Cottle

Founding Partner

Matt Harrison

CFO & Partner

Yair Erez

Head of Transformation & Partner

FAQ

When was Stanley Capital founded?

Stanley Capital was founded in 2019.

What type of investor is Stanley Capital?

Stanley Capital is a private equity firm.

Where is Stanley Capital headquartered?

Stanley Capital is headquartered in London, United Kingdom.

 Subscribe to unlock this and 197,084
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 188K M&A Transactions
  • 193K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 74K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal